Related Experiment Video
Updated: Apr 19, 2026
Generation of Retinal Organoids from Healthy and Retinal Disease-Specific Human-Induced Pluripotent Stem Cells
Published on: December 9, 2022
Stem cells as tools for studying the genetics of inherited retinal degenerations
Luke A Wiley1, Erin R Burnight1, Robert F Mullins1
1Stephen A. Wynn Institute for Vision Research, Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa 52242.
Abstract:
The ability to provide early clinical intervention for inherited disorders is heavily dependent on knowledge of a patient's disease-causing mutations and the resultant pathophysiologic mechanism(s). Without knowing a patient's disease-causing gene, and how gene mutations alter the health and functionality of affected cells, it would be difficult to develop and deliver patient-specific molecular or small molecule therapies. Many believe that the field of stem cell biology holds the keys to the future development of disease-, patient-, and cell-specific therapies. In the case of the eye, which is susceptible to an extremely common late-onset degenerative disease known as age-related macular degeneration, stem cell-based therapies could increase the quality of life for millions of patients worldwide. Furthermore, autologous, patient-specific induced pluripotent stem cells could be a viable source to treat rare Mendelian retinal degenerative diseases such as retinitis pigmentosa, Stargardt disease, and Best disease, to name a few.
Insights
Understanding genetic mutations is crucial for treating inherited disorders. Stem cell therapies, particularly induced pluripotent stem cells, show promise for treating eye diseases like retinitis pigmentosa.
Area of Science:
- Genetics and Regenerative Medicine
- Ophthalmology
Background:
- Effective treatment for inherited disorders requires knowledge of disease-causing mutations and their pathophysiological mechanisms.
- Patient-specific therapies depend on understanding how gene mutations affect cellular function.
Purpose of the Study:
- To highlight the potential of stem cell biology in developing personalized therapies for inherited diseases.
- To explore the application of stem cell-based treatments for retinal degenerative diseases.
Main Methods:
- Review of current understanding in stem cell biology and genetic disease mechanisms.
- Discussion of the potential of induced pluripotent stem cells (iPSCs) for therapeutic applications.
Main Results:
- Stem cell biology offers a pathway to disease-, patient-, and cell-specific therapies.
- Autologous iPSCs present a viable option for treating rare Mendelian retinal diseases.
Conclusions:
- Advancements in stem cell technology are pivotal for future therapeutic strategies.
- Stem cell therapies hold significant promise for improving patient quality of life, especially in ophthalmology.
Related Concept Videos
01:22iPS Cell Differentiation
01:13Induced Pluripotent Stem Cells
01:21EPS and iPS Cells in Disease Research